BIOMAT Database Logo BIOMAT Database Logo

Inhibition of Helicobacter pylori by acetohydroxamic acid. 1990

S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt

UI MeSH Term Description Entries
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D014510 Urease An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5. Phytourease,Urea Amidohydrolase,Amidohydrolase, Urea
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae
D016481 Helicobacter Infections Infections with organisms of the genus HELICOBACTER, particularly, in humans, HELICOBACTER PYLORI. The clinical manifestations are focused in the stomach, usually the gastric mucosa and antrum, and the upper duodenum. This infection plays a major role in the pathogenesis of type B gastritis and peptic ulcer disease. Infections, Helicobacter,Helicobacter Infection,Infection, Helicobacter

Related Publications

S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Cytotoxic activity of Helicobacter pylori enhanced by acetohydroxamic acid.
February 1994, Journal of clinical pathology,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Helicobacter pylori and plasma ammonia levels in cirrhotics: role of urease inhibition by acetohydroxamic acid.
August 1998, Italian journal of gastroenterology and hepatology,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Effect of inhibition of Helicobacter pylori urease activity by acetohydroxamic acid on serum gastrin in duodenal ulcer subjects.
August 1991, Gut,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Floating-bioadhesive microspheres containing acetohydroxamic acid for clearance of Helicobacter pylori.
January 2002, Drug delivery,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Floating microspheres bearing acetohydroxamic acid for the treatment of Helicobacter pylori.
December 2003, The Journal of pharmacy and pharmacology,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Antibacterial action of the urease inhibitor acetohydroxamic acid on Helicobacter pylori.
April 1993, Journal of clinical pathology,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Receptor-mediated targeting of lipobeads bearing acetohydroxamic acid for eradication of Helicobacter pylori.
September 2004, Journal of controlled release : official journal of the Controlled Release Society,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Marked reduction of Helicobacter pylori-induced gastritis by urease inhibitors, acetohydroxamic acid and flurofamide, in Mongolian gerbils.
July 2001, Biochemical and biophysical research communications,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
Inhibition of Helicobacter pylori urease activity by hydroxamic acid derivatives.
October 1994, Biological & pharmaceutical bulletin,
S J Veldhuyzen van Zanten, and J Goldie, and R H Hunt
In vitro inhibition of struvite crystal growth by acetohydroxamic acid.
October 1992, British journal of urology,
Copied contents to your clipboard!